Back to search

Article

Preparing for implementation of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis within the Brazilian public health system: The ImPrEP CAB Brasil Study

2023-11-20

Abstract excerpt

<h4>Introduction: </h4> Although long-acting injectable cabotegravir (CAB-LA) PrEP has proven efficacious for HIV prevention in clinical trials, additional research is needed to guide effective implementation in real world settings. <h4>Methods: </h4> ImPrEP CAB-Brasil is an implementation study of same-day delivery of CAB-LA PrEP for young sexual and gender minorities (SGM; aged 18-30 years) in six existing oral...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65dd69ce-c171-5959-b24e-2a61fc6ea563
DOI
10.21203/rs.3.rs-3607464/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preparing for implementation of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis within the Brazilian public health system: The ImPrEP CAB Brasil StudyDOI 10.21203/rs.3.rs-3607464/v1
Select a neighboring publication to make it the new centre.